Clinical Trials Browser

OTHER × Adenocarcinoma × Androgen Antagonists × Clear all

NCT07426055 2026-03-23

PRO-BOOST-LC

Phase 2/3 Recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07460726 2026-03-10

PRIAPUS-PCa

Not yet recruiting

Adenocarcinoma, Erectile Dysfunction, Prostatic Neoplasms

NCT07268794 2025-12-08

CONVERT-HB1

Phase 2 Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms